GLENMARK PHARMACEUTICALS
Back to Income Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Profit Before Tax History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Profit Before Tax | ₹240 Cr | ₹1,441 Cr | ₹1,382 Cr | ₹1,096 Cr | ₹1,301 Cr |
What is the latest Profit Before Tax of GLENMARK PHARMACEUTICALS ?
Year | Profit Before Tax |
---|---|
Mar2024 | ₹240 Cr |
Mar2023 | ₹1,441 Cr |
Mar2022 | ₹1,382 Cr |
Mar2021 | ₹1,096 Cr |
Mar2020 | ₹1,301 Cr |
How is Profit Before Tax of GLENMARK PHARMACEUTICALS Trending?
Years | Profit Before Tax | % Change | |
---|---|---|---|
Mar2024 | ₹240 Cr | -83.36 | |
Mar2023 | ₹1,441 Cr | 4.25 | |
Mar2022 | ₹1,382 Cr | 26.13 | |
Mar2021 | ₹1,096 Cr | -15.73 | |
Mar2020 | ₹1,301 Cr | - |
Compare Profit Before Tax of peers of GLENMARK PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLENMARK PHARMACEUTICALS | ₹60,894.5 Cr | -2.1% | 28% | 54.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹402,620.0 Cr | -1.3% | 1% | 7.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,509.0 Cr | -3.2% | -0.3% | 48% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,571.0 Cr | 1.2% | 10.7% | 19.5% | Stock Analytics | |
CIPLA | ₹118,336.0 Cr | -0.6% | -2.2% | -0.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹103,522.0 Cr | -1.5% | -5.9% | -5.1% | Stock Analytics |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLENMARK PHARMACEUTICALS | -2.1% |
28% |
54.5% |
SENSEX | -0.5% |
-0.3% |
1% |
You may also like the below Video Courses